ABHD6

ABHD6
Identifiers
AliasesABHD6, abhydrolase domain containing 6, abhydrolase domain containing 6, acylglycerol lipase
External IDsOMIM: 616966; MGI: 1913332; GeneCards: ABHD6
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
3.1.1.23↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_020676
NM_001320126

NM_025341
NM_001331064
NM_001331065

RefSeq (protein)

NP_001307055
NP_065727
NP_065727.4
NP_001307055.1

NP_001317993
NP_001317994
NP_079617

Location (UCSC)Chr 3: 58.24 – 58.3 MbChr 14: 14.41 – 14.47 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Monoacylglycerol lipase ABHD6, also known as alpha/beta-Hydrolase domain containing 6 (ABHD6), is an enzyme that in humans is encoded by the ABHD6 gene.

Function

ABHD6 is a serine hydrolyzing enzyme that possesses typical α/β-hydrolase family domains. ABHD6 was first studied because of its over-expression in certain forms of tumours.

ABHD6 has been linked to regulation of the endocannabinoid system as it controls the accumulation of 2-arachidonoylglycerol (2-AG) at the cannabinoid receptors.

ABHD6 accounts for about 4% of 2-AG brain hydrolysis. Together, monoacylglycerol lipase (MAGL), ABHD12, and ABHD6 control about 99% of 2-AG signalling in the brain, and each enzyme exhibits a distinct subcellular distribution, suggesting that they regulate distinct pools of 2-AG in the nervous system.

See also